Literature DB >> 3488712

Haemophilus influenzae type b meningitis resistant to ampicillin and chloramphenicol.

H Guiscafré, F Solórzano, O Delgado, O Muñoz.   

Abstract

We report two cases of meningitis due to Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. In one child the meningitis was preceded by pneumonia and pleural effusion. Both children responded to treatment with cefotaxime.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3488712      PMCID： PMC1777865          DOI： 10.1136/adc.61.7.691

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

Review 1.  Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature.

Authors:  P M Mendelman; C A Doroshow; S L Gandy; V Syriopoulou; C P Weigen; A L Smith
Journal:  J Infect Dis       Date:  1984-07       Impact factor: 5.226

2.  Therapeutic activity of ceftazidime and eleven other beta-lactam antibiotics against experimental Haemophilus influenzae, type b meningitis.

Authors:  A A McColm; D M Ryan
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

3.  Screening for ampicillin resistant Hemophilus influenzae and penicillin resistant Streptococcus Pneumoniae in healthy carriers.

Authors:  H Guiscafré; M García-Melgar; M Jaime; J A Trejo y Pérez; M García; R Hernández-Velarde; O Muñoz
Journal:  Arch Invest Med (Mex)       Date:  1981

4.  A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.

Authors:  R F Jacobs; T G Wells; R W Steele; T Yamauchi
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406
  4 in total
  1 in total

1.  Spread of non-typable multiply resistant Haemophilus influenzae in a South African hospital.

Authors:  C Heney; F Berkowitz; T Baise; M Cotton; M Khoosal; S Vally; R Barriere; J Saunders; H J Koornhof
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.